ALLMedicine™ Intermediate Uveitis Center
Research & Reviews 114 results
https://doi.org/10.1186/s12886-022-02404-z 10.1080/09273948.2016.1239745 10.1136/bjophthalmol-2015-308194 10.1186/s12348-016-0079-y 10.1080/09273940801899822 10.1016/j.ajo.2005.03.057 10.1136/bjo.60.3.163 10.1016/S0002-9394(01)00925-4 10.1016/j.clim.2019.108322 10.1016/j.survophthal.2019.12.003 10.1186/s12886-019-1139-5 10.1016/j.jaapos.2019.04.008 10.1080/09273948.2017.1420202 10.1080/09273948.2018.1535079 10.3109/09273948.2015.1012298 10.1016/S2352-4642(19)30027-6 10.3109/09273948.2016.1158279 10.1097/BOR.0000000000000620 10.1038/s41433-018-0214-0 10.1159/000328630 10.1016/j.exer.2008.10.004 10.1097/BOR.0000000000000316 10.3928/15428877-20091230-19 10.1016/S0161-6420(93)31568-X 10.1080/09273948.2016.1213855
BMC Ophthalmology; Sun N, Wang C et. al.
Apr 20th, 2022 - To analyse demographic, clinical features, treatment and therapeutic outcomes of pediatric uveitis and scleritis patients. The clinical records of pediatric uveitis and scleritis cases between January 2012 and December 2020 at a tertiary uveitis s...
https://doi.org/10.1093/milmed/usac092
Military Medicine; Lhaiba M, Caré W et. al.
Apr 13th, 2022 - Assessment of the medical fitness to serve in the armed forces has two objectives: to prevent the military operations from being jeopardized by a medical issue, and to protect soldiers from the sequelae of diseases that could become complicated in...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966567
BMJ Case Reports; Basiron SF', Khaw AML et. al.
Mar 31st, 2022 - An adolescent female with underlying bilateral pseudophakia and idiopathic intermediate uveitis had reduced visual acuity due to posterior capsule opacification (PCO). The rapid progression and different morphological formations of Elschnig pearls...
https://doi.org/10.1016/j.ajo.2021.11.003
American Journal of Ophthalmology; AlBloushi AF, Solebo AL et. al.
Nov 16th, 2021 - To describe the course of childhood-onset intermediate uveitis without associated systemic disease, and investigate determinants of outcomes. A retrospective clinical cohort study METHODS: This study was conducted in an institutional setting. A to...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406922
Pediatric Rheumatology Online Journal; Iriqat S, Safieh MA et. al.
Sep 2nd, 2021 - This case study documents the first familial case of Blau syndrome (BS) in Palestine characterized with mutation in CARD15/NOD2. Eighteen years old female was initially misdiagnosed with Juvenile idiopathic arthritis (JIA). The patient had been on...
Guidelines 1 results
https://doi.org/10.1016/j.ophtha.2020.06.052
Ophthalmology Agrawal R, Testi I et. al.
Jul 1st, 2020 - The Collaborative Ocular Tuberculosis Study (COTS), supported by the International Ocular Inflammation Society, International Uveitis Study Group, and Foster Ocular Immunological Society, set up an international, expert-led consensus project to de...
Clinicaltrials.gov 4 results
https://clinicaltrials.gov/ct2/show/NCT01124838
Jul 7th, 2021 - A study comparing the safety and efficacy of adalimumab compared with. placebo in adults with inactive non-infectious intermediate uveitis, posterior uveitis, or panuveitis.
https://clinicaltrials.gov/ct2/show/NCT02911116
Mar 26th, 2021 - Objective: Uveitis refers to intraocular inflammatory diseases that are an important cause of visual loss. Standard systemic immunosuppressive medications for uveitis can cause significant adverse effects and many patients continue to experience d...
https://clinicaltrials.gov/ct2/show/NCT01505088
Mar 29th, 2013 - Anterior uveitis is a disorder of the eye associated with intraocular inflammation of the anterior portion of the uvea, particularly the iris and/or ciliary body. It is distinct from other iterations of uveitis such as posterior, diffuse and inter...
https://clinicaltrials.gov/ct2/show/NCT00344253
Dec 3rd, 2012 - Deuter et al were the first to show the anti-edematous effect of interferon alpha on inflammatory macular edema (Deuter C. M. E., Kötter I., Günaydin I., Zierhut M. Treatment of the Cystoid Macular Oedema in Behçet's Disease with Interferon Alfa-2...
News 6 results
https://www.mdedge.com/rheumatology/article/207854/ankylosing-spondylitis/two-uveitis-treatment-options-yield-similar
Heidi Splete
Sep 10th, 2019 - Approximately two-thirds of adults with uveitis achieved inflammation control after 6 months on either methotrexate or mycophenolate alongside a reduction in corticosteroid use in an international, multicenter, open-label, randomized trial. “The f.
https://www.medpagetoday.com/ophthalmology/generalophthalmology/69384
Nov 19th, 2017 - Development of technologies for sustained drug delivery is a topic of great interest among retina specialists, considering the number of chronic conditions that are managed with repeated intravitreal injections. Products in this category are alrea...
https://www.staging.medscape.com/viewarticle/865654
Jul 1st, 2016 - The US Food and Drug Administration (FDA) has approved adalimumab (Humira, AbbVie) for use in patients with noninfectious intermediate and posterior uveitis and panuveitis, the company announced. Adalimumab is the first and only FDA-approved nonco...
https://www.medscape.com/viewarticle/865654
Jul 1st, 2016 - The US Food and Drug Administration (FDA) has approved adalimumab (Humira, AbbVie) for use in patients with noninfectious intermediate and posterior uveitis and panuveitis, the company announced. Adalimumab is the first and only FDA-approved nonco...
https://www.medscape.com/viewarticle/769952
Aug 29th, 2012 - August 29, 2012 — The US Food and Drug Administration (FDA) has granted orphan drug status to gevokizumab (Xoma 052, Xoma Corp), a monoclonal antibody that binds strongly to interleukin 1β (IL-1β), for the treatment of noninfectious intermediate u...
